Chinese vaccine makers Sinovac, Sinopharm and CanSinoBio applied to join WHO's COVAX scheme
20 Jan 2021 / 16:11 H.
BEIJING, Jan 20 (Reuters) - Chinese COVID-19 vaccine developers Sinovac, Sinopharm and Cansino Bio have submitted application to join COVAX, a global schemed backed by the World Health Organization, foreign ministry spokeswoman Hua Chunying said on Wednesday. (Reporting by Cate Cadell, editing by Louise Heavens)
Did you like this article?
